

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.55101069 |
| 2 | cardiac myofibril assembly (GO:0055003) | 5.24289749 |
| 3 | cellular response to epinephrine stimulus (GO:0071872) | 5.14424435 |
| 4 | response to epinephrine (GO:0071871) | 5.14151919 |
| 5 | coronary vasculature morphogenesis (GO:0060977) | 5.04691454 |
| 6 | midgut development (GO:0007494) | 4.98247939 |
| 7 | carnitine shuttle (GO:0006853) | 4.74207984 |
| 8 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.50340446 |
| 9 | adrenergic receptor signaling pathway (GO:0071875) | 4.50031109 |
| 10 | detection of calcium ion (GO:0005513) | 4.37953055 |
| 11 | myofibril assembly (GO:0030239) | 4.25399272 |
| 12 | heart trabecula formation (GO:0060347) | 4.08152889 |
| 13 | fatty acid transmembrane transport (GO:1902001) | 4.04972801 |
| 14 | atrial septum morphogenesis (GO:0060413) | 4.03108865 |
| 15 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.01894958 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98895494 |
| 17 | sarcomere organization (GO:0045214) | 3.98103069 |
| 18 | cardiac muscle hypertrophy (GO:0003300) | 3.96475986 |
| 19 | cardiac muscle cell development (GO:0055013) | 3.96439027 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 3.92156889 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.90625928 |
| 22 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.83663565 |
| 23 | positive regulation of heart rate (GO:0010460) | 3.80888203 |
| 24 | homocysteine metabolic process (GO:0050667) | 3.79453818 |
| 25 | cardiac cell development (GO:0055006) | 3.79016316 |
| 26 | carnitine transmembrane transport (GO:1902603) | 3.75875596 |
| 27 | striated muscle hypertrophy (GO:0014897) | 3.73890568 |
| 28 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.71042864 |
| 29 | cardiac right ventricle morphogenesis (GO:0003215) | 3.68869162 |
| 30 | response to caffeine (GO:0031000) | 3.63903005 |
| 31 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.62890991 |
| 32 | heart valve formation (GO:0003188) | 3.58949900 |
| 33 | * cAMP catabolic process (GO:0006198) | 3.55542229 |
| 34 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.51038963 |
| 35 | amino-acid betaine transport (GO:0015838) | 3.45810846 |
| 36 | carnitine transport (GO:0015879) | 3.45810846 |
| 37 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.44394265 |
| 38 | striated muscle contraction (GO:0006941) | 3.43603906 |
| 39 | glomerular basement membrane development (GO:0032836) | 3.41676939 |
| 40 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.39475007 |
| 41 | positive regulation of heart contraction (GO:0045823) | 3.39344032 |
| 42 | muscle hypertrophy (GO:0014896) | 3.38725986 |
| 43 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.36954886 |
| 44 | regulation of relaxation of muscle (GO:1901077) | 3.35565150 |
| 45 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.34713375 |
| 46 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.34502665 |
| 47 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.33645687 |
| 48 | ventricular cardiac muscle cell development (GO:0055015) | 3.31601586 |
| 49 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.30206188 |
| 50 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.29918638 |
| 51 | trabecula formation (GO:0060343) | 3.28392324 |
| 52 | regulation of cardioblast differentiation (GO:0051890) | 3.28198475 |
| 53 | * cyclic nucleotide catabolic process (GO:0009214) | 3.27707544 |
| 54 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.25255439 |
| 55 | muscle hypertrophy in response to stress (GO:0003299) | 3.25255439 |
| 56 | cardiac muscle adaptation (GO:0014887) | 3.25255439 |
| 57 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.23317411 |
| 58 | adult heart development (GO:0007512) | 3.22024904 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.21952900 |
| 60 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.20820234 |
| 61 | glomerulus development (GO:0032835) | 3.19182024 |
| 62 | desmosome organization (GO:0002934) | 3.18174620 |
| 63 | cardiac muscle contraction (GO:0060048) | 3.15870897 |
| 64 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.14774501 |
| 65 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.13470664 |
| 66 | negative regulation of complement activation (GO:0045916) | 3.13339968 |
| 67 | regulation of sarcomere organization (GO:0060297) | 3.12968490 |
| 68 | pericardium development (GO:0060039) | 3.12044273 |
| 69 | endocardial cushion morphogenesis (GO:0003203) | 3.11498603 |
| 70 | muscle tissue morphogenesis (GO:0060415) | 3.10994036 |
| 71 | glomerular filtration (GO:0003094) | 3.10588435 |
| 72 | cell migration involved in heart development (GO:0060973) | 3.10041494 |
| 73 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.09617922 |
| 74 | actomyosin structure organization (GO:0031032) | 3.09593025 |
| 75 | outflow tract septum morphogenesis (GO:0003148) | 3.08248281 |
| 76 | cell proliferation involved in metanephros development (GO:0072203) | 3.07341292 |
| 77 | regulation of cardiac muscle contraction (GO:0055117) | 3.07061171 |
| 78 | positive regulation of heart growth (GO:0060421) | 3.05691389 |
| 79 | regulation of smooth muscle cell differentiation (GO:0051150) | 3.04966614 |
| 80 | response to catecholamine (GO:0071869) | 3.04796913 |
| 81 | response to monoamine (GO:0071867) | 3.04796913 |
| 82 | actin-mediated cell contraction (GO:0070252) | 3.04685406 |
| 83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03341907 |
| 84 | regulation of heart contraction (GO:0008016) | 3.02594233 |
| 85 | atrioventricular valve morphogenesis (GO:0003181) | 3.02447449 |
| 86 | cellular response to catecholamine stimulus (GO:0071870) | 2.98851427 |
| 87 | cellular response to monoamine stimulus (GO:0071868) | 2.98851427 |
| 88 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.98525267 |
| 89 | response to dexamethasone (GO:0071548) | 2.98520608 |
| 90 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.98082264 |
| 91 | regulation of striated muscle contraction (GO:0006942) | 2.97956166 |
| 92 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.97719057 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.97337073 |
| 94 | tonic smooth muscle contraction (GO:0014820) | 2.97190189 |
| 95 | relaxation of cardiac muscle (GO:0055119) | 2.94342751 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93529292 |
| 97 | nuclear pore complex assembly (GO:0051292) | 2.91042262 |
| 98 | cell proliferation involved in kidney development (GO:0072111) | 2.90864988 |
| 99 | renal filtration (GO:0097205) | 2.88871324 |
| 100 | glomerular visceral epithelial cell development (GO:0072015) | 2.87733234 |
| 101 | response to inactivity (GO:0014854) | 2.85705991 |
| 102 | mesenchyme morphogenesis (GO:0072132) | 2.85090643 |
| 103 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.84047249 |
| 104 | regulation of skeletal muscle contraction (GO:0014819) | 2.83133420 |
| 105 | muscle filament sliding (GO:0030049) | 2.82809613 |
| 106 | actin-myosin filament sliding (GO:0033275) | 2.82809613 |
| 107 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.82531612 |
| 108 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.82531612 |
| 109 | mesenchymal cell development (GO:0014031) | 2.81585672 |
| 110 | cell communication involved in cardiac conduction (GO:0086065) | 2.81515558 |
| 111 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.81013449 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 2.80870913 |
| 113 | tricarboxylic acid cycle (GO:0006099) | 2.80666167 |
| 114 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.80417565 |
| 115 | smooth muscle tissue development (GO:0048745) | 2.79846459 |
| 116 | heart process (GO:0003015) | 2.79343733 |
| 117 | heart contraction (GO:0060047) | 2.79343733 |
| 118 | urea cycle (GO:0000050) | 2.78477622 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.78392055 |
| 120 | venous blood vessel morphogenesis (GO:0048845) | 2.75508965 |
| 121 | heart morphogenesis (GO:0003007) | 2.75322956 |
| 122 | regulation of ATP catabolic process (GO:1903289) | 2.74969834 |
| 123 | regulation of ATPase activity (GO:0043462) | 2.74969834 |
| 124 | citrulline biosynthetic process (GO:0019240) | 2.74418648 |
| 125 | notochord development (GO:0030903) | 2.74143098 |
| 126 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.73164880 |
| 127 | Notch signaling involved in heart development (GO:0061314) | 2.72735721 |
| 128 | regulation of cardiac muscle tissue growth (GO:0055021) | 2.72317037 |
| 129 | embryonic heart tube development (GO:0035050) | 2.71852265 |
| 130 | regulation of the force of heart contraction (GO:0002026) | 2.71537444 |
| 131 | * cGMP-mediated signaling (GO:0019934) | 2.70748741 |
| 132 | cellular response to glucagon stimulus (GO:0071377) | 2.67405558 |
| 133 | regulation of heart rate (GO:0002027) | 2.67393650 |
| 134 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.66517894 |
| 135 | gap junction assembly (GO:0016264) | 2.66446114 |
| 136 | negative regulation of heart contraction (GO:0045822) | 2.65957148 |
| 137 | metanephric mesenchyme development (GO:0072075) | 2.64211706 |
| 138 | regulation of cardiac muscle tissue development (GO:0055024) | 2.63394252 |
| 139 | heart valve morphogenesis (GO:0003179) | 2.62460853 |
| 140 | plasma membrane repair (GO:0001778) | 2.60648314 |
| 141 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.60171314 |
| 142 | regulation of vasculogenesis (GO:2001212) | 2.59658965 |
| 143 | cell communication by electrical coupling (GO:0010644) | 2.58064758 |
| 144 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.57848423 |
| 145 | cardiac muscle cell action potential (GO:0086001) | 2.57809746 |
| 146 | actin filament-based movement (GO:0030048) | 2.54429325 |
| 147 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.53666455 |
| 148 | positive regulation of muscle hypertrophy (GO:0014742) | 2.52358813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.49866952 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.51139489 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.45238868 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.95612285 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.66613990 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.55401431 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54358245 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.49936915 |
| 9 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.45666170 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43264805 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.36472658 |
| 12 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27935384 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.18862164 |
| 14 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.17669443 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13431390 |
| 16 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07363084 |
| 17 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07363084 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06023208 |
| 19 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05083569 |
| 20 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02488518 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.02273465 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02116632 |
| 23 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96444037 |
| 24 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94813042 |
| 25 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94257391 |
| 26 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89114345 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82417660 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75629509 |
| 29 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71438941 |
| 30 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70516230 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.70430438 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69056671 |
| 33 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68690040 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68472862 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.66389482 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63911401 |
| 37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.62106507 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.61500407 |
| 39 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59514420 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54569935 |
| 41 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.53716060 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51896639 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51766042 |
| 44 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.51570267 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48019137 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47501733 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45399092 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44149347 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43818992 |
| 50 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.43271712 |
| 51 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40477425 |
| 52 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40218052 |
| 53 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.39485444 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37687255 |
| 55 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37212492 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34626126 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33931513 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33764026 |
| 59 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33195888 |
| 60 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33195888 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32504380 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32355958 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30598580 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29556128 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29368319 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.28468277 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27433740 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27357671 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27167615 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26880053 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26880053 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26679638 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26453734 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26170721 |
| 75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25700738 |
| 76 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25067333 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25048425 |
| 78 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.24797649 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23813606 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22801376 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22420360 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20448663 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20416630 |
| 84 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19948927 |
| 85 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19791047 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19436409 |
| 87 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.18332400 |
| 88 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.18271136 |
| 89 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.17914008 |
| 90 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17844861 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15793552 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15666090 |
| 93 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14501638 |
| 94 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.13677317 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11727216 |
| 96 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11694008 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11455306 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11169746 |
| 99 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10253555 |
| 100 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.06954901 |
| 101 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06793516 |
| 102 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.06544461 |
| 103 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06004027 |
| 104 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05722500 |
| 105 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.04846721 |
| 106 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04354068 |
| 107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04034826 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03276063 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02688075 |
| 110 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02649143 |
| 111 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02506956 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02500467 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02304263 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02237976 |
| 115 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01946786 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00562410 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 1.00432426 |
| 118 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98890573 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98638620 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98399399 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97679319 |
| 122 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96896904 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96571998 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96455180 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96392733 |
| 126 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95731809 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95265262 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94612726 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94232172 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93331281 |
| 131 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92507363 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92423881 |
| 133 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91408823 |
| 134 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90831841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.01272217 |
| 2 | MP0004084_abnormal_cardiac_muscle | 3.73768968 |
| 3 | MP0000751_myopathy | 3.51944631 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.47215975 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.23325991 |
| 6 | MP0009384_cardiac_valve_regurgitation | 3.12980044 |
| 7 | MP0004272_abnormal_basement_membrane | 2.88645614 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.71637520 |
| 9 | MP0005330_cardiomyopathy | 2.70397185 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.67148600 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.66049911 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.64928777 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.44412264 |
| 14 | MP0003279_aneurysm | 2.44064209 |
| 15 | MP0006138_congestive_heart_failure | 2.43843932 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.41466181 |
| 17 | MP0005670_abnormal_white_adipose | 2.32770870 |
| 18 | MP0002127_abnormal_cardiovascular_syste | 2.30157986 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.18944779 |
| 20 | MP0004085_abnormal_heartbeat | 2.12080015 |
| 21 | MP0004484_altered_response_of | 2.06501822 |
| 22 | MP0003941_abnormal_skin_development | 2.04828480 |
| 23 | MP0000749_muscle_degeneration | 2.03244431 |
| 24 | MP0003137_abnormal_impulse_conducting | 2.02647481 |
| 25 | MP0003646_muscle_fatigue | 2.01492414 |
| 26 | MP0005385_cardiovascular_system_phenoty | 1.92094002 |
| 27 | MP0001544_abnormal_cardiovascular_syste | 1.92094002 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.84439189 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.73969913 |
| 30 | MP0002108_abnormal_muscle_morphology | 1.73398584 |
| 31 | MP0005275_abnormal_skin_tensile | 1.72371213 |
| 32 | MP0003136_yellow_coat_color | 1.71127829 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.69395702 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.69377791 |
| 35 | MP0003828_pulmonary_edema | 1.66204948 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.58443753 |
| 37 | MP0003385_abnormal_body_wall | 1.55164888 |
| 38 | MP0001958_emphysema | 1.52848581 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.50257597 |
| 40 | MP0005369_muscle_phenotype | 1.38899266 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.38875159 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.36905560 |
| 43 | MP0005187_abnormal_penis_morphology | 1.35675083 |
| 44 | MP0009250_abnormal_appendicular_skeleto | 1.35092811 |
| 45 | MP0002295_abnormal_pulmonary_circulatio | 1.34493363 |
| 46 | MP0002106_abnormal_muscle_physiology | 1.33669597 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.26656250 |
| 48 | MP0005595_abnormal_vascular_smooth | 1.24440802 |
| 49 | MP0001299_abnormal_eye_distance/ | 1.23650502 |
| 50 | MP0000230_abnormal_systemic_arterial | 1.22632616 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.21256091 |
| 52 | MP0000566_synostosis | 1.19967305 |
| 53 | MP0000579_abnormal_nail_morphology | 1.19686544 |
| 54 | MP0003122_maternal_imprinting | 1.16158475 |
| 55 | MP0004130_abnormal_muscle_cell | 1.14398994 |
| 56 | MP0010030_abnormal_orbit_morphology | 1.07886033 |
| 57 | MP0005409_darkened_coat_color | 1.07769843 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07465333 |
| 59 | MP0003787_abnormal_imprinting | 1.07342250 |
| 60 | MP0005083_abnormal_biliary_tract | 1.06523939 |
| 61 | MP0002009_preneoplasia | 1.06304021 |
| 62 | MP0000462_abnormal_digestive_system | 1.04440684 |
| 63 | MP0000266_abnormal_heart_morphology | 1.04423882 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.03908940 |
| 65 | MP0003935_abnormal_craniofacial_develop | 1.02951691 |
| 66 | MP0002822_catalepsy | 1.01490881 |
| 67 | MP0004233_abnormal_muscle_weight | 0.98590454 |
| 68 | MP0003942_abnormal_urinary_system | 0.98492908 |
| 69 | MP0002128_abnormal_blood_circulation | 0.97422657 |
| 70 | MP0000759_abnormal_skeletal_muscle | 0.96860049 |
| 71 | MP0000049_abnormal_middle_ear | 0.96176351 |
| 72 | MP0001270_distended_abdomen | 0.95972102 |
| 73 | MP0005248_abnormal_Harderian_gland | 0.95452533 |
| 74 | MP0002938_white_spotting | 0.95231106 |
| 75 | MP0005508_abnormal_skeleton_morphology | 0.95044787 |
| 76 | MP0001188_hyperpigmentation | 0.94856895 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.94511706 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.94140861 |
| 79 | MP0004510_myositis | 0.93043874 |
| 80 | MP0003045_fibrosis | 0.93010014 |
| 81 | MP0002269_muscular_atrophy | 0.92730050 |
| 82 | MP0003937_abnormal_limbs/digits/tail_de | 0.90606747 |
| 83 | MP0002925_abnormal_cardiovascular_devel | 0.88308466 |
| 84 | MP0000534_abnormal_ureter_morphology | 0.86689305 |
| 85 | MP0006054_spinal_hemorrhage | 0.85213057 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.84404249 |
| 87 | MP0002249_abnormal_larynx_morphology | 0.84307800 |
| 88 | MP0001661_extended_life_span | 0.84277793 |
| 89 | MP0000428_abnormal_craniofacial_morphol | 0.83037465 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.80357320 |
| 91 | MP0000747_muscle_weakness | 0.79785611 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.79107241 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.78821677 |
| 94 | MP0001614_abnormal_blood_vessel | 0.78542541 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.78218607 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.77593133 |
| 97 | MP0005171_absent_coat_pigmentation | 0.76583110 |
| 98 | MP0005165_increased_susceptibility_to | 0.76262945 |
| 99 | MP0003984_embryonic_growth_retardation | 0.76025780 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.75432386 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 0.73991790 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.73709667 |
| 103 | MP0002697_abnormal_eye_size | 0.73647385 |
| 104 | MP0004134_abnormal_chest_morphology | 0.73189545 |
| 105 | MP0000163_abnormal_cartilage_morphology | 0.73175809 |
| 106 | MP0000013_abnormal_adipose_tissue | 0.72145735 |
| 107 | MP0003283_abnormal_digestive_organ | 0.71768953 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.71273184 |
| 109 | MP0002133_abnormal_respiratory_system | 0.71008332 |
| 110 | MP0005388_respiratory_system_phenotype | 0.71008332 |
| 111 | MP0000733_abnormal_muscle_development | 0.70997269 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.70130768 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.68058572 |
| 114 | MP0003121_genomic_imprinting | 0.66645171 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65850577 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.64979782 |
| 117 | MP0000516_abnormal_urinary_system | 0.64979782 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.64172321 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.64168911 |
| 120 | MP0008004_abnormal_stomach_pH | 0.61025193 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.60715356 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.59670354 |
| 123 | MP0005253_abnormal_eye_physiology | 0.59140792 |
| 124 | MP0002090_abnormal_vision | 0.58358207 |
| 125 | MP0009697_abnormal_copulation | 0.57644521 |
| 126 | MP0008057_abnormal_DNA_replication | 0.57430876 |
| 127 | MP0001984_abnormal_olfaction | 0.54633562 |
| 128 | MP0010678_abnormal_skin_adnexa | 0.54564160 |
| 129 | MP0003091_abnormal_cell_migration | 0.53636547 |
| 130 | MP0000383_abnormal_hair_follicle | 0.51353327 |
| 131 | MP0005380_embryogenesis_phenotype | 0.50192506 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.50192506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.41118927 |
| 2 | Atrial fibrillation (HP:0005110) | 4.76206801 |
| 3 | Primary atrial arrhythmia (HP:0001692) | 4.37136206 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.30652256 |
| 5 | Broad metatarsal (HP:0001783) | 4.27152642 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.22086236 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 4.15582269 |
| 8 | Supraventricular tachycardia (HP:0004755) | 4.13508905 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.05678447 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 4.03098808 |
| 11 | Aortic aneurysm (HP:0004942) | 4.02171052 |
| 12 | Syncope (HP:0001279) | 3.98973175 |
| 13 | Prolonged QT interval (HP:0001657) | 3.83869717 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.78844492 |
| 15 | Lipoatrophy (HP:0100578) | 3.77587623 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.69346316 |
| 17 | Pulmonary artery stenosis (HP:0004415) | 3.42754124 |
| 18 | Dysmetric saccades (HP:0000641) | 3.41119030 |
| 19 | Aortic dissection (HP:0002647) | 3.36497649 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.31450922 |
| 21 | Subaortic stenosis (HP:0001682) | 3.31450922 |
| 22 | Muscle fiber splitting (HP:0003555) | 3.30807767 |
| 23 | Midline defect of the nose (HP:0004122) | 3.15380914 |
| 24 | Hypoplastic ischia (HP:0003175) | 3.00464683 |
| 25 | Blue irides (HP:0000635) | 2.96922006 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 2.94716077 |
| 27 | Short 4th metacarpal (HP:0010044) | 2.93408084 |
| 28 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.93408084 |
| 29 | Abnormality of the 4th metacarpal (HP:0010012) | 2.82687269 |
| 30 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.77460852 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 2.76911605 |
| 32 | Abnormality of the ischium (HP:0003174) | 2.74479902 |
| 33 | Abnormality of the parietal bone (HP:0002696) | 2.73685086 |
| 34 | Short hallux (HP:0010109) | 2.72881651 |
| 35 | Chorioretinal atrophy (HP:0000533) | 2.72377001 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.67270626 |
| 37 | Ventricular arrhythmia (HP:0004308) | 2.62288836 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.60859159 |
| 39 | Shallow orbits (HP:0000586) | 2.60010144 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58598352 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 2.58598352 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.54640004 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.48154538 |
| 44 | Bundle branch block (HP:0011710) | 2.46600293 |
| 45 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.39638940 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.38921694 |
| 47 | Increased connective tissue (HP:0009025) | 2.38175986 |
| 48 | Abnormality of the tricuspid valve (HP:0001702) | 2.36785446 |
| 49 | Abnormal EKG (HP:0003115) | 2.34930660 |
| 50 | Aneurysm (HP:0002617) | 2.31711579 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.30994723 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.27823695 |
| 53 | Stroke (HP:0001297) | 2.26409814 |
| 54 | Exercise-induced muscle cramps (HP:0003710) | 2.25444876 |
| 55 | Bone cyst (HP:0012062) | 2.25442839 |
| 56 | Ankle contracture (HP:0006466) | 2.24357484 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.23712682 |
| 58 | Premature rupture of membranes (HP:0001788) | 2.18677373 |
| 59 | Limited hip movement (HP:0008800) | 2.18643427 |
| 60 | Hip contracture (HP:0003273) | 2.17455812 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.15508341 |
| 62 | Submucous cleft hard palate (HP:0000176) | 2.14431456 |
| 63 | Vitreoretinal degeneration (HP:0000655) | 2.14074166 |
| 64 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10700175 |
| 65 | Vascular tortuosity (HP:0004948) | 2.09518141 |
| 66 | Aplasia cutis congenita (HP:0001057) | 2.09272165 |
| 67 | Palpitations (HP:0001962) | 2.09037289 |
| 68 | Fair hair (HP:0002286) | 2.08188703 |
| 69 | Heart block (HP:0012722) | 2.06046919 |
| 70 | Short chin (HP:0000331) | 2.05615130 |
| 71 | Difficulty running (HP:0009046) | 2.04894616 |
| 72 | Myotonia (HP:0002486) | 2.04437179 |
| 73 | Spinal rigidity (HP:0003306) | 2.02686123 |
| 74 | Abnormal atrioventricular conduction (HP:0005150) | 2.01147939 |
| 75 | Hypoplastic left heart (HP:0004383) | 2.00259781 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 1.99451379 |
| 77 | Neck muscle weakness (HP:0000467) | 1.98955518 |
| 78 | EMG: myopathic abnormalities (HP:0003458) | 1.98397810 |
| 79 | Scapular winging (HP:0003691) | 1.97914557 |
| 80 | Atrioventricular block (HP:0001678) | 1.93383051 |
| 81 | Bell-shaped thorax (HP:0001591) | 1.93122485 |
| 82 | Impaired pain sensation (HP:0007328) | 1.92320942 |
| 83 | Abnormality of pain sensation (HP:0010832) | 1.92320942 |
| 84 | Mesomelia (HP:0003027) | 1.91466304 |
| 85 | Abnormality of the nasal septum (HP:0000419) | 1.90981836 |
| 86 | Wormian bones (HP:0002645) | 1.90912615 |
| 87 | Left ventricular hypertrophy (HP:0001712) | 1.90843356 |
| 88 | Wrist flexion contracture (HP:0001239) | 1.89636301 |
| 89 | Abnormality of the right ventricle (HP:0001707) | 1.88647535 |
| 90 | Mitral stenosis (HP:0001718) | 1.87933841 |
| 91 | Palmoplantar keratoderma (HP:0000982) | 1.86871105 |
| 92 | Trigonocephaly (HP:0000243) | 1.86628500 |
| 93 | Bradycardia (HP:0001662) | 1.85702782 |
| 94 | Bladder diverticulum (HP:0000015) | 1.85582352 |
| 95 | Sudden cardiac death (HP:0001645) | 1.85398731 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85358025 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 1.84931625 |
| 98 | Nasolacrimal duct obstruction (HP:0000579) | 1.84720991 |
| 99 | Steppage gait (HP:0003376) | 1.84640445 |
| 100 | Abnormal auditory evoked potentials (HP:0006958) | 1.83718166 |
| 101 | Rimmed vacuoles (HP:0003805) | 1.83502070 |
| 102 | Overgrowth (HP:0001548) | 1.82518197 |
| 103 | Exostoses (HP:0100777) | 1.82010980 |
| 104 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81632376 |
| 105 | Vertebral arch anomaly (HP:0008438) | 1.81419643 |
| 106 | Knee flexion contracture (HP:0006380) | 1.80475953 |
| 107 | Rectal prolapse (HP:0002035) | 1.79363202 |
| 108 | Abnormality of glycolysis (HP:0004366) | 1.79126527 |
| 109 | Pheochromocytoma (HP:0002666) | 1.78510396 |
| 110 | Hypoventilation (HP:0002791) | 1.73659194 |
| 111 | Myoglobinuria (HP:0002913) | 1.73344087 |
| 112 | Toxemia of pregnancy (HP:0100603) | 1.72466885 |
| 113 | Scotoma (HP:0000575) | 1.71949788 |
| 114 | Muscular dystrophy (HP:0003560) | 1.70965385 |
| 115 | Lymphangioma (HP:0100764) | 1.70381367 |
| 116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.69947722 |
| 117 | Hypoplasia of the iris (HP:0007676) | 1.69296390 |
| 118 | Cerebellar dysplasia (HP:0007033) | 1.68499516 |
| 119 | Elbow flexion contracture (HP:0002987) | 1.68438745 |
| 120 | Central scotoma (HP:0000603) | 1.68007540 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 1.66872325 |
| 122 | Hyperalaninemia (HP:0003348) | 1.66872325 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66872325 |
| 124 | Broad ribs (HP:0000885) | 1.65893204 |
| 125 | Potter facies (HP:0002009) | 1.65803096 |
| 126 | Facial shape deformation (HP:0011334) | 1.65803096 |
| 127 | Abnormality of incisor morphology (HP:0011063) | 1.65650807 |
| 128 | Preaxial foot polydactyly (HP:0001841) | 1.65270582 |
| 129 | Papillary thyroid carcinoma (HP:0002895) | 1.64843545 |
| 130 | Wide anterior fontanel (HP:0000260) | 1.64628187 |
| 131 | Mild short stature (HP:0003502) | 1.63980408 |
| 132 | Alkalosis (HP:0001948) | 1.63774890 |
| 133 | Increased serum pyruvate (HP:0003542) | 1.63679835 |
| 134 | Mesangial abnormality (HP:0001966) | 1.60744172 |
| 135 | Abnormality of the lacrimal duct (HP:0011481) | 1.60380837 |
| 136 | Congenital stationary night blindness (HP:0007642) | 1.59683797 |
| 137 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.58625404 |
| 138 | Follicular hyperkeratosis (HP:0007502) | 1.58341911 |
| 139 | Abnormality of the nasolacrimal system (HP:0000614) | 1.58221705 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.55989316 |
| 141 | Aplasia of the phalanges of the hand (HP:0009802) | 1.55989316 |
| 142 | Congestive heart failure (HP:0001635) | 1.55049428 |
| 143 | White forelock (HP:0002211) | 1.53662709 |
| 144 | Generalized muscle weakness (HP:0003324) | 1.52849464 |
| 145 | Increased circulating renin level (HP:0000848) | 1.51238669 |
| 146 | Subacute progressive viral hepatitis (HP:0006572) | 1.50239195 |
| 147 | Soft skin (HP:0000977) | 1.50050951 |
| 148 | Foot dorsiflexor weakness (HP:0009027) | 1.48167624 |
| 149 | Proximal amyotrophy (HP:0007126) | 1.47156564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 5.53131944 |
| 2 | DMPK | 3.75051735 |
| 3 | TTN | 3.06723451 |
| 4 | LMTK2 | 2.93174092 |
| 5 | ZAK | 2.84764001 |
| 6 | TIE1 | 2.83024666 |
| 7 | INSRR | 2.68217480 |
| 8 | LATS1 | 2.64964711 |
| 9 | STK38L | 2.49395748 |
| 10 | OBSCN | 2.44779620 |
| 11 | PDGFRA | 2.43596147 |
| 12 | MST1R | 2.28429383 |
| 13 | EPHB2 | 2.28030827 |
| 14 | NUAK1 | 2.04899975 |
| 15 | PIK3CA | 2.03382677 |
| 16 | ACVR1B | 1.89638948 |
| 17 | PHKG2 | 1.89394080 |
| 18 | PHKG1 | 1.89394080 |
| 19 | PAK3 | 1.82984017 |
| 20 | AKT3 | 1.82202332 |
| 21 | EPHA3 | 1.73850046 |
| 22 | EEF2K | 1.62902422 |
| 23 | WNK4 | 1.59505870 |
| 24 | GRK7 | 1.59160366 |
| 25 | DDR2 | 1.57444491 |
| 26 | CDC42BPA | 1.56981154 |
| 27 | ROCK1 | 1.53759493 |
| 28 | FRK | 1.51134870 |
| 29 | NEK9 | 1.42092835 |
| 30 | BRSK2 | 1.41087908 |
| 31 | OXSR1 | 1.40235478 |
| 32 | STK24 | 1.39132939 |
| 33 | WNK1 | 1.38051323 |
| 34 | NEK1 | 1.37012890 |
| 35 | MKNK1 | 1.31552202 |
| 36 | PAK2 | 1.28388781 |
| 37 | CASK | 1.24013342 |
| 38 | PBK | 1.21782735 |
| 39 | PRKAA2 | 1.16054918 |
| 40 | MUSK | 1.14806964 |
| 41 | STK39 | 1.14048687 |
| 42 | PRKD1 | 1.13908967 |
| 43 | RIPK1 | 1.10855253 |
| 44 | FGFR2 | 1.09621299 |
| 45 | FER | 1.08901655 |
| 46 | NEK6 | 1.03784254 |
| 47 | STK4 | 1.00801746 |
| 48 | TGFBR2 | 1.00662688 |
| 49 | MAPKAPK5 | 1.00425336 |
| 50 | PDK4 | 0.99623644 |
| 51 | PDK3 | 0.99623644 |
| 52 | PDGFRB | 0.99235344 |
| 53 | MAPK12 | 0.99218730 |
| 54 | MARK1 | 0.98258878 |
| 55 | PRKCE | 0.97321096 |
| 56 | LATS2 | 0.91679563 |
| 57 | CAMK2D | 0.88818018 |
| 58 | RPS6KB2 | 0.85736128 |
| 59 | GRK1 | 0.85221882 |
| 60 | SIK1 | 0.85063776 |
| 61 | TGFBR1 | 0.84690783 |
| 62 | PINK1 | 0.83647155 |
| 63 | PRKAA1 | 0.81197162 |
| 64 | TRPM7 | 0.78183905 |
| 65 | MARK2 | 0.77619767 |
| 66 | ADRBK1 | 0.75791503 |
| 67 | PKN1 | 0.75374699 |
| 68 | SGK2 | 0.74602621 |
| 69 | MTOR | 0.72316244 |
| 70 | CAMK1G | 0.71968307 |
| 71 | STK38 | 0.70812208 |
| 72 | AKT2 | 0.70181602 |
| 73 | STK11 | 0.67390619 |
| 74 | CAMK2A | 0.67132774 |
| 75 | PRKCH | 0.67125084 |
| 76 | CAMK1 | 0.65960655 |
| 77 | CAMK4 | 0.65110759 |
| 78 | ICK | 0.64872999 |
| 79 | SGK494 | 0.64852102 |
| 80 | SGK223 | 0.64852102 |
| 81 | WEE1 | 0.62570021 |
| 82 | CDK9 | 0.60110271 |
| 83 | TRIB3 | 0.59471573 |
| 84 | MAP2K7 | 0.58252443 |
| 85 | CAMK2B | 0.57394850 |
| 86 | CAMKK2 | 0.54724189 |
| 87 | ROCK2 | 0.54685841 |
| 88 | MAPK7 | 0.54079396 |
| 89 | ILK | 0.54045012 |
| 90 | MET | 0.53854661 |
| 91 | PDK2 | 0.53753738 |
| 92 | CDK3 | 0.53722924 |
| 93 | MAP3K6 | 0.53376652 |
| 94 | SGK3 | 0.52633269 |
| 95 | ERBB2 | 0.52453053 |
| 96 | PRKD2 | 0.52018720 |
| 97 | PRKG1 | 0.50825950 |
| 98 | CAMK1D | 0.50279604 |
| 99 | PRKACB | 0.50185605 |
| 100 | STK3 | 0.48839877 |
| 101 | PTK2B | 0.48783061 |
| 102 | BRD4 | 0.48470858 |
| 103 | MAPKAPK3 | 0.47283220 |
| 104 | ERBB3 | 0.46895868 |
| 105 | MAP3K7 | 0.46471133 |
| 106 | CAMK2G | 0.46269822 |
| 107 | TTK | 0.45990359 |
| 108 | MAPK4 | 0.45484991 |
| 109 | FGFR1 | 0.44957154 |
| 110 | FGFR3 | 0.43547597 |
| 111 | PRKG2 | 0.43390436 |
| 112 | BMPR2 | 0.42797088 |
| 113 | RPS6KA5 | 0.42103285 |
| 114 | PRKD3 | 0.41944614 |
| 115 | PKN2 | 0.41486211 |
| 116 | * PRKACA | 0.39879934 |
| 117 | NTRK1 | 0.39164559 |
| 118 | MAPK11 | 0.38998690 |
| 119 | PIK3CG | 0.38083428 |
| 120 | SGK1 | 0.37780347 |
| 121 | LIMK1 | 0.36519953 |
| 122 | NLK | 0.34195301 |
| 123 | MELK | 0.34045489 |
| 124 | RPS6KL1 | 0.33009006 |
| 125 | RPS6KC1 | 0.33009006 |
| 126 | CDK6 | 0.32979844 |
| 127 | GSK3A | 0.32723875 |
| 128 | PTK2 | 0.32501706 |
| 129 | TLK1 | 0.32245011 |
| 130 | RET | 0.31790160 |
| 131 | KDR | 0.31430443 |
| 132 | SCYL2 | 0.30732757 |
| 133 | RPS6KA1 | 0.29612685 |
| 134 | PNCK | 0.29383974 |
| 135 | MAP3K4 | 0.28286081 |
| 136 | ERBB4 | 0.27793396 |
| 137 | MAPK13 | 0.26572542 |
| 138 | MAP2K1 | 0.25522758 |
| 139 | IGF1R | 0.24758126 |
| 140 | BCR | 0.23352106 |
| 141 | BMPR1B | 0.22923328 |
| 142 | PRKACG | 0.20251340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.94958748 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.71232928 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.21977769 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.49709781 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.48560476 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44461903 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39854085 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27022575 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.23939704 |
| 10 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 2.04522106 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 2.04285971 |
| 12 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.76910782 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.59253281 |
| 14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58112855 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56058466 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52478320 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.46316738 |
| 18 | * Renin secretion_Homo sapiens_hsa04924 | 1.44863694 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.44487592 |
| 20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.40480095 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36960642 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30859826 |
| 23 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29096690 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28176589 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25361727 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24929582 |
| 27 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.22954583 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.22462883 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 1.20491496 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20266030 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.20082249 |
| 32 | Axon guidance_Homo sapiens_hsa04360 | 1.18985587 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18025832 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15690762 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15642145 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.14008481 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 1.12880523 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09993618 |
| 39 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.09327757 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09256409 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04455781 |
| 42 | Melanoma_Homo sapiens_hsa05218 | 1.03654033 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.01091761 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99026977 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98769189 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 0.98634281 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97667270 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97484095 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 0.96047153 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.92569132 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91902055 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91710583 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91560944 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91012573 |
| 55 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.90722106 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.90374535 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85245466 |
| 58 | Alcoholism_Homo sapiens_hsa05034 | 0.83751980 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82537092 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82355256 |
| 61 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.82248213 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81656089 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.80840688 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80828590 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80571330 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.80553050 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80355481 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80196135 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79398990 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.79219761 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78845282 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77970968 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76561266 |
| 74 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76316990 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76139685 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.75313811 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75253431 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75129992 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74566845 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74406960 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73781111 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72385073 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72168588 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72125776 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71728265 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71562883 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71409954 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70532889 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.69958361 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68099330 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65981078 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65980941 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65795468 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.65720576 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63700889 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.63401541 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62829217 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62356181 |
| 99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62321082 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61392217 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60393874 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60316060 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59265744 |
| 104 | * Morphine addiction_Homo sapiens_hsa05032 | 0.59097363 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57092123 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57087580 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56580092 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56358664 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55819820 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.55520807 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54342102 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53778645 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53769496 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50139434 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49469198 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49259374 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48239486 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47726463 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44965416 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44594530 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41957716 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41767085 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40662943 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.40449917 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40063634 |
| 126 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39780703 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39478592 |
| 128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39050869 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38629761 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35731743 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35157687 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34787877 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33402041 |
| 134 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31812574 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30495251 |

